TC Biopharm (Holdings) Plc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| WOLVERINE ASSET MANAGEMENT LLC | 02/03/2025 | 668.32 K | $6.62 K | 100.00% | 2.22% |
| KEPOS CAPITAL LP | 02/11/2025 | 470.59 K | $5.00 K | 0.00% | 1.56% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 02/14/2025 | 235.29 K | $2.33 K | 0.00% | 0.78% |
| CSENGE ADVISORY GROUP | 01/30/2025 | 23.86 K | $236 | 26.51% | 0.08% |
| UBS GROUP AG | 02/14/2025 | 2.40 K | $24 | 103.22% | 0.01% |
| ARMISTICE CAPITAL, LLC | 02/14/2025 | 188 | $2 | 100.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| ALTIUM CAPITAL MANAGEMENT LP | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
TC Biopharm (Holdings) Plc institutional Ownership - FAQ's
During the previous two years, 1 institutional investors and hedge funds held shares of TC Biopharm (Holdings) Plc. The most heavily invested institutionals were:
Empery Asset Management, LP: 2.82 M
4.65% of TC Biopharm (Holdings) Plc stock is owned by institutional investors.
Institutional investors have bought a total of 2.82 M shares in the last 24 months. This purchase volume represents approximately $28.24 K in transactions.